跳至主要内容
临床试验/ACTRN12626000962336
ACTRN12626000962336进行中(未招募)不适用

Lipid Incorporation through poly-unsaturated fatty acid (PUFA) Supplementation: Yielding Nutrient-driven Cellular responses

Baker Heart and Diabetes Institute0 个研究点目标入组 60 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • Healthy male and female volunteers aged 18–45 years with a body mass index (BMI) between 18.5 and 28 kg/m². Participants must be willing and able to provide written informed consent, comply with all study procedures, attend study visits, and consume the allocated omega-3 supplement for 4 weeks.

排除标准

  • Individuals with a history of cardiovascular disease, diabetes, cancer, chronic inflammatory or autoimmune disease, liver or kidney disease, or other clinically significant medical conditions. Current use of omega-3 supplements or medications known to influence lipid metabolism or immune function, allergy to fish or fish oil, pregnancy or breastfeeding, current smoking or excessive alcohol consumption, participation in another clinical trial within the previous 30 days, or any condition that, in the opinion of the investigators, would make participation unsafe or interfere with study completion.

研究者

相似试验